Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK team joins race to develop blood test for Alzheimer's disease

This article was originally published in Clinica

Executive Summary

A team of UK researchers is joining the race to develop a blood-based test for Alzheimer's disease (AD), with two biomarkers that it says could diagnose the disease up to two years before current clinical diagnostic methods. It may also provide a means of monitoring ongoing disease progress, and may prove useful in monitoring clinical trials of AD drugs, said the researchers, led by Simon Lovestone, at Kings College London's MRC Centre for Neurodegeneration Research.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT053364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel